Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status
Cliodhna Quigley(University College Dublin), Frank S. French(University of North Carolina at Chapel Hill), Ronald G. Lafrenière(Xenon Pharmaceuticals (Canada)), Anthony Johnson(University College Hospital), Dennis B. Lubahn(University of Missouri), H F Willard(University of North Carolina at Chapel Hill), Lawrence M. Silverman(University of North Carolina at Chapel Hill), Elizabeth M. Wilson(University of North Carolina at Chapel Hill), T. R. Brown(Johns Hopkins University), Kenneth J. Friedman(Rutgers, The State University of New Jersey)
Cited by 104
Related Papers
Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society
|Endocrinology|2012|1.2k
Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity.
|Proceedings of the National Academy of Sciences|1989|447
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
|Pharmacological Reviews|2006|430
Androgen receptor gene mutations in human prostate cancer.
|Proceedings of the National Academy of Sciences|1992|420
Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia
|New England Journal of Medicine|2021|384